The company utilizes DNA polymerase (DNAP) from multiple suppliers in all PCR reactions. Synthesized DNA templates are also procured from various providers. For Therapeutic DNA Production Services, inputs such as DNAP may be optimized for specific sources, and discontinuation of DNAP from a single supplier could result in production delays. The Linea RNAP product is manufactured exclusively by a third-party contract development and manufacturing organization (CDMO) based in the United States. The company produces GLP-grade DNA at its Stony Brook facility using the LineaDNA platform.
Suppliers referenced in company filings include 4basebio PLC, Aldevron, LLC, ANSA Biotechnologies, Bitmine Immersion Technologies Inc., Blue Heron Biotech, LLC, CEA Industries, Inc., Elegen, Inc., Forward Industries, Inc., Gene Art, GenScript Biotech Corporation, Integrated DNA Technologies, Inc., MaxCyte, Inc., Merck & Co., Inc., MilliporeSigma, Novartis AG, OriGene Technologies, Inc., Precigen, Inc., Quantoom Bioscience, Sharplink Gaming Inc., Solana Company, Strategy, Inc., Syngoi Technologies, S.L.U., The Ether Machine, and Touchlight Genetics Ltd.
Bnb Plus's Comment on Supply Chain
The company utilizes DNA polymerase (DNAP) from multiple suppliers in all PCR reactions. Synthesized DNA templates are also procured from various providers. For Therapeutic DNA Production Services, inputs such as DNAP may be optimized for specific sources, and discontinuation of DNAP from a single supplier could result in production delays. The Linea RNAP product is manufactured exclusively by a third-party contract development and manufacturing organization (CDMO) based in the United States. The company produces GLP-grade DNA at its Stony Brook facility using the LineaDNA platform.
Suppliers referenced in company filings include 4basebio PLC, Aldevron, LLC, ANSA Biotechnologies, Bitmine Immersion Technologies Inc., Blue Heron Biotech, LLC, CEA Industries, Inc., Elegen, Inc., Forward Industries, Inc., Gene Art, GenScript Biotech Corporation, Integrated DNA Technologies, Inc., MaxCyte, Inc., Merck & Co., Inc., MilliporeSigma, Novartis AG, OriGene Technologies, Inc., Precigen, Inc., Quantoom Bioscience, Sharplink Gaming Inc., Solana Company, Strategy, Inc., Syngoi Technologies, S.L.U., The Ether Machine, and Touchlight Genetics Ltd.
Sources:
Bnb Plus Corp 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Bnb Plus Corp ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
